Implant Sciences Corp. Ships Explosives Detection Equipment to China

Company sells initial order of 101 Quantum Sniffer units to China Railway Administration


Implant Sciences, incorporated in 1984, is using its core ion technology to develop, manufacture and market products for the homeland security, semiconductor and medical device industries. The Company has developed and commercialized portable and bench-top detection devices to identify explosives which are distributed under the Quantum Sniffer(TM) brand name. The Company also provides state of the art ion implantation and wafer analytical services for the semiconductor industry. The Company also develops, manufactures and sells radioactive products for the treatment of cancer, including sales of radioactive seeds for the treatment of prostate cancer and development of a new, FDA approved radioactive source for use in the treatment of breast cancer. For further details on the Company and its products please visit the Company's website at www.implantsciences.com.

Implant Sciences believes that this release contains forward-looking statements that are subject to risks and uncertainties. Such statements are based on management's current expectations and are subject to facts that could cause results to differ materially from the forward-looking statements. For further information you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission.

CONTACT: Implant Sciences Corporation Investor Relations (781) 246-0700, ext. 105 www.implantsciences.com KEYWORD: MASSACHUSETTSINDUSTRY KEYWORD: MANUFACTURING PHARMACEUTICAL MEDICAL DEVICES AIRLINES TRANSPORTATION HARDWARE LEGAL/LAW AEROSPACE/DEFENSE GOVERNMENT PRODUCTSOURCE: Implant Sciences Corporation

<<Business Wire -- 11/10/05>>